Back
Endava PLC Vs. Edgewise Therapeutics Industry Stock Comparison
Buy
63
DAVA
Endava PLC
Last Price:
30.82
Seasonality Move:
-8.46%
Buy
68
EWTX
Edgewise Therapeutics
Last Price:
30.17
Seasonality Move:
30.89%
Buy
63
Endava PLC (DAVA)
is a Buy
Is Endava PLC a Buy, Sell or Hold?
- The current Endava PLC [DAVA] share price is $30.21. The Score for DAVA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- DAVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $32.69. The Score for EWTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVA Stock Price Chart
What is Endava PLC's stock price today?
-
The Endava PLC share price today is $30.21
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAVA is experiencing slight buying pressure.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $32.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing slight buying pressure.
DAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.92 | Buy |
| Relative Strength Index (14 RSI): | 63.8 | Buy |
| Chaikin Money Flow: | 282282 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.5 - 29.94) | Buy |
| Bollinger Bands (100): | (25.65 - 30.81) | Buy |
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 54.58 | Buy |
| Chaikin Money Flow: | 961676 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.01 - 33.47) | Buy |
| Bollinger Bands (100): | (19.14 - 33.32) | Buy |
DAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.94 | Buy |
| 20-day SMA: | 28.77 | Buy |
| 50-day SMA: | 26.87 | Buy |
| 200-day SMA: | 29.8 | Buy |
| 8-day EMA: | 29.87 | Buy |
| 20-day EMA: | 28.96 | Buy |
| 50-day EMA: | 28.04 | Buy |
| 200-day EMA: | 33.63 | Sell |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.27 | Buy |
| 20-day SMA: | 31.27 | Buy |
| 50-day SMA: | 32.55 | Buy |
| 200-day SMA: | 22.1 | Buy |
| 8-day EMA: | 30.36 | Buy |
| 20-day EMA: | 31.19 | Buy |
| 50-day EMA: | 30.63 | Buy |
| 200-day EMA: | 23.28 | Buy |
Endava PLC Earnings Growth & DAVA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.16 per share, and a decrease next year of $0.05 per share.
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.34 per share.
Endava PLC Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edgewise Therapeutics Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||